Child Psychiatry - Articles - Page 4

Clinical Update

Update on Escitalopram

January 1, 2025

Mariel Zeccola, APRN, PhD. Nurse practitioner in private practice, Westport, CT.

Dr. Zeccola has no financial relationships with companies related to this material.

Where does escitalopram fit in the treatment of anxiety, depression, OCD, and other disorders of children and adolescents? We review the data and help you decide where to place escitalopram in your own practice.

Expert Q&A

Addressing the Overdose Crisis: What You Can Do

January 1, 2025

Aaron Quiggle, MD, MS

Aaron Quiggle, MD, MS

Adult, child, and adolescent addiction psychiatrist; Medical Director, Addiction Recovery Management Service (ARMS), Massachusetts General Hospital, Boston, MA.

Dr. Quiggle is a co-investigator of an investigator-sponsored trial for Ironshore Pharmaceuticals. Relevant financial relationships have been mitigated.

There are multiple ways that we can help our patients reduce the risk of overdose. In our interview with Dr. Aaron Quiggle, we cover screening, fentanyl testing, the use of Narcan and the importance of learning to prescribe buprenorphine.

Clinical Update

Substance Use Treatment in Teens: What Level of Care?

January 1, 2025

Dhruv Shah, DO and Brady Heward, MD

Dhruv Shah, DO. Assistant Professor, University of Vermont Medical Center, Burlington, VT.

Brady Heward, MD. Assistant Professor, University of Vermont Medical Center, Burlington, VT; Clinical Instructor, Yale School of Medicine, New Haven, CT.

Dr. Heward has no financial relationships with companies related to this material. Dr. Shah has served as a consultant for HPS Brain Gym. Relevant financial relationships have been mitigated.

One of the most challenging problems in adolescent care is figuring out what level of care will give patients the best chance of recovery or progress. We give you a guide to decide what level of care to recommend based on your individual patient.

Research Update

How Safe Is Methylphenidate?

October 1, 2024

Earth Hasassri, MD

Earth Hasassri, MD. Dr. Hasassri has no financial relationships with companies related to this material.

Most of us use methylphenidate (MPH) routinely in patients across a wide range of ages and even diagnoses. But what are the long-term side effects of MPH? This research update gives you a current understanding of the potential risks with helpful guidance on how to proceed with care.

Research Update

Stimulants in Preschool-Age Children

October 1, 2024

Earth Hasassri, MD

Earth Hasassri, MD. Dr. Hasassri has no financial relationships with companies related to this material.

We are understandably hesitant to treat young children with medication for ADHD. Does it work? Will there be worse or different side effects? This research update will help you weigh the risks and benefits of pursuing stimulant treatment for ADHD in our smallest patients.

Expert Q&A

Early Childhood Psychiatric Care

October 1, 2024

Jeffrey Rowe, MD

Jeffrey Rowe, MD

Private practice, San Diego, CA; associate clinical professor, University of California at San Diego School of Medicine (Retired); co-chair, “We Can’t Wait” Early Childhood Mental Health Conference, 2010–2024.

Dr. Rowe has no financial relationships with companies related to this material.

Mental health problems in young children are incredibly complex. Dr. Jeffrey Rowe’s comprehensive outline helps us organize our assessment and care planning for these children. Even more important, since most of us see older kids, Dr. Rowe helps us find the links between problems in early childhood and later mental health challenges.

Clinical Update

Practical Advocacy in Child and Adolescent Psychiatry

October 1, 2024

Abishek Bala, MD, MPH

Abishek Bala, MD, MPH. Director, Psychiatry Clerkship; Assistant Program Director, Child & Adolescent Psychiatry Fellowship; Assistant Professor, Central Michigan University, Saginaw, MI.

Dr. Bala has no financial relationships with companies related to this material

We all want to offer comprehensive care that includes every team member: therapists, teachers, parents, and even the child. This is a daunting task, and our clinical update gives you the reasoning to share and the ideas you can use to pursue this ideal with your patients and their families.

Expert Q&A

Treating ADHD in Young Children

October 1, 2024

Natalie Pon, MD

Natalie Pon, MD

Child and adolescent psychiatrist, Children’s Health Council; adjunct clinical faculty, Stanford University, Palo Alto, CA.

Dr. Pon has no financial relationships with companies related to this material.

What does ADHD look like in young children? How do we differentiate it from just another active toddler? And if a young child really does have ADHD, how do we treat it? Our interview with Dr. Natalie Pon will help you identify and treat ADHD in young children.

Clinical Update

Dysregulation in Autism: Irritability, Aggression, and “Pathological Demand Avoidance”

October 1, 2024

Alyssa Aikman, MSN, APRN, PMHNP-BC

Alyssa Aikman, MSN, APRN, PMHNP-BC. Psychiatric nurse practitioner in outpatient group practice, Vancouver, WA.

Ms. Aikman has no financial relationships with companies related to this material.

Pathological demand avoidance (PDA) is a popular concern among autistic kids and families. It’s not in the DSM, yet we need to understand and address it. This clinical update helps you approach irritability and PDA rationally to help autistic patients connect and regulate before merely prescribing D2-blocking antipsychotics.